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E-mail address: ghriazi@ibb.ut.ac.ir (G. Riazi).Tau isoforms promote neuronal integrity through binding and stabilization of microtubule proteins
(MTP). It has been shown that hyperphosphorylation of tau contributes to Alzheimer’s disease (AD)
pathology and related tauopathies. However, other pathogenic modiﬁcations of tau have not been
well characterized. It is well accepted that elevated level of homocysteine (Hcy) is associated with
neurodegenerative diseases such as AD. As a result of N-homocysteinylation of lysine residues,
Hcy becomes a component of proteins, as a protein–homocystamide adduct, which affects protein
structure and function. Here we demonstrate that N-homocysteinylation of human tau (4R/1N iso-
form) inhibits its function via impaired tau–tubulin speciﬁc binding and MTP assembly dynamics
in vitro.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Elevated blood concentrations of homocysteine (Hcy) has been
recognized as an independent risk factor for Alzheimer’s disease
(AD) [1,2]. One of the proposed mechanisms of the toxicity of
Hcy is the chemical modiﬁcation of proteins by homocysteine thio-
lactone (tHcy), a reactive metabolite of Hcy [3,4]. tHcy can be
formed as a consequence of an error-editing reaction, through
the activity of tRNA synthetases, in pathogenic conditions. In pro-
tein biosynthesis, the non-protein amino acid Hcy, undergoes a
selectivity problem, because of its similarity to methionine, leucine
and isoleucine. Indeed, Hcy enters the initial step of protein bio-
synthesis and forms Hcy-AMP with methionyl-, leucyl- and isoleu-
cyl-tRNA synthetases. Misactivated Hcy never incorporate into the
protein structure and instead, destroys to form activated thioester,
tHcy [4]. Due to electron withdrawing activity of this thioester, the
pKa of the amine group of tHcy is 7.1, which is lower than primary
amine groups in amino acids side chains. tHcy was shown to
acylate e-amino groups of lysine side chains irreversibly in a non-
enzymatic process so-called ‘‘N-homocysteinylation’’, which causes
loss of positive charges and introduction of thiol groups to a pro-
tein molecule as Scheme 1 [5]. As a result, N-homocysteinylationchemical Societies. Published by E
ent of Biochemistry, Institute
4155-6461 Tehran, Iran. Fax:causes a change of the protein’s physicochemical properties and
an extensive impact on its biological function [3,5].
The microtubule protein (MTP) network is highly dynamic and
plays a crucial role in many cellular processes such as cell division
and intracellular transport [6]. MTP dynamic instability is regu-
lated by microtubule-associated proteins (MAPs) [7]. Tau is an
essential MAP of the neuronal cytoskeleton and exists as six alter-
natively spliced isoforms, arising from a single gene located on
chromosome 17 [8]. Isoforms differ from one another by the pres-
ence or absence of a 29 or 58 amino acid insert in the N-terminal
half (0, 1 and 2 N) and by the inclusion, or exclusion, of a 31 amino
acid repeat, encoded by exon 10 of tau, in the C-terminal half of the
protein [9]. These highly conserved repeats constitute the MTP
binding region of tau; therefore C-terminal part of tau encom-
passes either three or four (3R and 4R) contiguous microtubule-
binding repeats (MTBRs) [10]. It has been found these isoforms
stabilize MTP both in vitro and in vivo and 4R tau stabilizes MTP
more strongly and also overexpresses in AD condition in compare
to 3R form [11,12]. In this way, the positive lysine residues in the
MTBRs of tau interact with the negative C-terminal of tubulin in
a sequence-speciﬁc fashion [13]. Disruption of the interaction be-
tween tau and MTP either through mutation or modiﬁcation in
the MTBRs would result in the release of tau from MTP. Unbinding
from MTP, tau may aggregate to form paired helical ﬁlaments
(PHFs) [8,14]. Thus, tau binding to MTP plays an essential role in
both physiological and pathological states [15].lsevier B.V. All rights reserved.
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ing phosphorylation [16], acetylation [17], glycosylation [18], ubiq-
uitinylation [19], oxidation [20], or glycation [21]. In all of these
modiﬁcations, the binding potential of tau to MTP undergoes sig-
niﬁcant changes [15].
These reports beside the knowledge that lysines, in MTBR of tau,
are critical to the binding to MTP, prompted us to speciﬁcally
investigate the effect of tau (4R/1N) N-homocysteinylation on its
binding activities to MTP. It is likely that tau-induced conforma-
tional states of tubulin are responsible for the assembly properties
and dynamic instability of MTP; then we addressed the issue of
whether N-homocysteinylated tau can induce assembly behavior
changes of MTP.
2. Materials and methods
2.1. Materials
Ethylenebis (oxyethylenenitrilo) tetraacetic acid (EGTA), guano-
sine-50-triphosphate type II-S (GTP), adenosine-50-triphosphate
(ATP), phenylmethylsulphonyl ﬂuoride (PMSF), dithiothreitol
(DTT), glycerol, MgSO4, homocysteine thiolactone (tHcy), dithioni-
trobenzoic acid (DTNB) and taxol were purchased from Sigma
(Deisenhofen, Germany). Piperazine-1,4-bis(2-ethanesulfonic acid)
(PIPES) was purchased from Merck (Darmstadt, Germany). MgSO4,
1 M, was added to both GTP and ATP 100 mM stock solutions, as a
ratio of 1:10 (v/v). Deionized and nanopure water was used in all
buffers.
2.2. Puriﬁcation of tau and tubulin
The pRK-T41construct containing cDNA sequence of the human
brain tau amino acid isoform (4R/1N) was kindly supplied by Dr. J.
Avila (Universidad Autonoma de Madrid, Spain). The digested frag-
ment of pRK-T41 with NdeI/EcoRI was subcloned to pET23-NHis
vector, constructed from the pET-23d by adding six consecutive
histidine residues to the N-terminal of the protein as Histag. For
protein overexpression, pET23-NHis plasmid was transformed into
BL21(DE3) competent cells and puriﬁed as described previously
[22]. Concentration of tau protein was determined from the
absorption at 280 nm with an extinction coefﬁcient of 7450 cm1 -
M1, adjusted to 35 lM, and its purity estimated with SDS–PAGE
(12%) Coomassie Brilliant Blue staining. For MTP assembly assays,
tau samples were dialyzed against 100 mM PIPES, and 1 mM DTT
at pH 6.8.
MTP was isolated from cow brain by two cycles of temperature-
dependent assembly and disassembly induced by 1 mM MgGTP in
PEM buffer (100 mM PIPES, 1 mM EGTA, 1 mMMgSO4, 1 mM PMSF
and 1 mM MgATP, pH 6.9). To obtain MAP-free tubulin, protein
sample was applied to a P11 phosphocellulose column (Whatman,
Piscataway, NJ) and eluted tubulin fractions were stored at 70 C
within two weeks. The resulting tubulin was essentially pure
(>98%) as determined by SDS–PAGE (10%), Coomassie Brilliant Blue
staining. Tubulin concentration was assessed by the Bradford re-
agent (Bio-Rad Laboratories, Hercules, CA), using serum albumin
as standard and justiﬁed to 25 lM for further experiments.
2.3. Preparation of N-homocysteinylated tau
Tau (35 lM) was extensively dialyzed against phosphate buffer
(50 mM and pH 7.4) at 4 C for 24 h prior to modiﬁcation. N-
homocysteinylated tau (N-Hcy-tau) was prepared by incubation
of tau protein with increasing tHcy ﬁnal concentrations (0.15, 1.5
and 15 mM) at 37 C for 18 h [23]. Unreacted tHcy and hydrolysis
products were removed by ultraﬁltration through a 10 kD cutoff
membrane (Millipore, Billerica, MA) at 4 C.2.4. Quantiﬁcation of sulfhydryl groups
After treatment of N-Hcy-tau species with 5 mM DTT for 10 min
and at room temperature, they were ultraﬁltrated through a 10 kD
cutoff membrane (Millipore, Billerica, MA). The extent of modiﬁca-
tion was quantiﬁed by assaying for free sulfhydryl groups using
DTNB. The increase in absorbance at 412 nm, due to thion-
itrobenzoate (TNB) release, was calculated using the extinction
coefﬁcient of 13600 cm1 M1 [24].
2.5. MTP binding and assembly assays
Ability of modiﬁed tau to bind to MTP was examined by incuba-
tion of N-Hcy-tau species (10 lM) with taxol-stabiliazed MTP
(25 lM) in assembly buffer (100 mM PIPES, 1 mM EGTA, 1 mM
MgSO4, 1 mM DTT, 1 mM MgGTP, pH 6.9) for 30 min at 37 C. Fol-
lowing a 20 min ultracentrifugation, aliquots of supernatants (tau
not bound to MTP) and pellets (tau bound to MTP) were subjected
to SDS–PAGE and stained with Coomassie Brilliant Blue. Density of
individual bands was estimated by 1-D Total Lab TL120 software
(Nonlinear Dynamics Ltd., UK).
To study the effect of modiﬁed tau to promote MTP assembly,
N-Hcy-tau species (10 lM) was incubated with tubulin (25 lM)
in assembly buffer for 15 min at 37 C. The assembly of tubulin into
MTP was detected over time by measuring the turbidity at 350 nm
using a Cary (Varian, AU) UV/vis spectrophotometer.
2.6. Determination of tubulin critical concentration
To determine the effect of modiﬁed tau on the critical concen-
tration (Cc) and unassembled fractions of tubulin (Fi), tubulin
(25 lM) was assembled in the presence or absence of unmodiﬁed
or N-Hcy-tau species (10 lM) in the assembly buffer for 30 min
at 37 C. At the steady state, aliquots of the sample were diluted
to different ﬁnal concentrations of tubulin (Ct), followed by re-
achievement of the steady state and separation of unassembled
tubulin from MTP by ultracentrifugation. After passing through a
P11 phosphocellulose column (Whatman, Piscataway, NJ), the
tubulin concentration in the supernatant (Cs) was determined by
the Bradford reagent (Bio-Rad Laboratories, Hercules, CA), using
serum albumin as standard and Cc and Fi were calculated as the
intercept and slope of a plot of Cs versus Ct, respectively [25].
2.7. Electron microscopy
Aliquots from assembly buffer were placed on 200 mesh grid,
coated with Formvar-carbon, and stained dropwise with 1.0% ura-
nyl acetate. The air dried samples were examined in a Philips
EM208 transmission electron microscope, operated at 90 kV.
2.8. Statistics
Each experiment was carried out in triplicate and values are the
means and standard deviations of three experiments. Results were
analyzed for statistical signiﬁcance using a two tailed student’s t
test. Changes were considered signiﬁcant at P values less than
0.05. All statistics were performed with Sigma Plot Version 12
(Systat Software Inc., CA) and presented as the mean ± SD.
3. Results and discussion
Alteration of functional properties of proteins can be a conse-
quence of pathophysiological accumulation of reactive metabolites
that have the potential to induce protein modiﬁcations.
Tau isoforms are intrinsically basic, unfolded proteins and 4R/
1N isoform contains 43 lysine residues. Net charge and isoelectric
Scheme 1. Mechanism of N-homocysteinylation and incorporation of thiol group into proteins.
Table 1
Molar formation of homocystamide adducts upon treatment of tau (4R/1N) with tHcy.
tHcy (mM) –Homocystamide/tau (4R/1N) molar ratio
0 0.09 ± 0.01
0.15 1.64 ± 0.17
1.5 7.18 ± 0.84
15 25.20 ± 0.13
Stoichiometry of homocystamide adducts formation by tHcy. The determination
was performed by DTNB, chromogenic measuring of the increase of absorbance at
412 nm, and by calculation with the extinction coefﬁcient of 13600 cm1 M1.
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modulating the assembly dynamics [26]. Due to the overexpres-
sion of four-reaped tau isoforms in pathological conditions and
solvent accessibility of their lysines, this isoforms are more suscep-
tible to N-homocysteinylation.
The malfunction of tau in nervous system appears to be likely
related to its MTP interaction. Therefore, we planned to investigate
the contribution of tau 4R/1N N-homocysteinylation in this pro-
cess. For assaying the molar formation of homocystamide–tau ad-
ducts, the increase in protein thiol groups was monitored with
respect to control tau. To avoid extensive oxidation of new thiol
groups in N-Hcy-tau species, we performed the assays using DTNB,Tau not bound to MTP (supernatant)
Con. N-Hcy-tau 
tHcy (mM) 0 0.15 1.5 15
tau
tubulin
Fig. 1. MTP binding assay of unmodiﬁed tau (Con.) and N-Hcy-tau species. Following inc
at 37 C, samples were precipitated into pellet and supernatant and subjected to SDS–PA
is shown here.
Table 2
Densitometric analysis of co-sedimented N-Hcy-tau with taxol-stabilized MTP.
tHcy (mM) Tau not bound to MTP (supernatant)
Con. N-Hcy-tau
0 0.15 1.5
Tau density% 28.86 30.99 65.27
Tubulin density% 19.37 20.65 20.02
N-Hcy-tau and tubulin densities (supernatant + pellet)%. SDS–PAGE gels were quantitat
densities of bands were measured in pixel concentration and are given in percentage of t
for tubulin. Samples were run in triplicate.after treatment the samples with DTT (Table 1). This ﬁnding was
supported by site-speciﬁc mass spectrometry analysis (unpub-
lished data).
Kinetic stabilization of MTP, is pivotal for its physiological roles
such as maintenance of axonal transportation [6]. This stabilization
widely depends on efﬁcient binding of MAPs [26]. Binding ability of
tau isoforms to MTP can be partially inhibited by missense muta-
genesis or modiﬁcations of lysine residues, particularly in MTBRs
[27]. To assess the signiﬁcance of tau N-homocysteinylation, we
determined the ability of N-Hcy-tau to binding to MTP. Co-
sedimentation studies of tau and taxol-stabilized MTP showed that
the degree of N-homocysteinylation inﬂuences the ability of tau to
bind to MTP. The distribution of N-Hcy-tau between the pellet
(bound to MTP) and supernatant (not bound toMTP) after ultracen-
trifugation, was markedly different from that observed with the
unmodiﬁed tau (Fig. 1). In particular, a large fraction of N-Hcy-tau
was recovered in the supernatant in a dose dependent manner of
tHcy, indicating that it was not bound to MTP. This suggests that
N-homocysteinylation of tau results in a reduced afﬁnity of tau
for the MTP (see Table 2).
Native tau binds to MTP, but more importantly, it regulates
nucleation and assembly characteristics of tubulin. Many studies
have been performed on the ability of abnormal tau to regulate
MTP nucleation and assembly processes [28]. We therefore asked Tau bound to MTP (pellet) 
Con. N-Hcy-tau 
 0 0.15 1.5 15 
ubation of N-Hcy-tau species (10 lM) with taxol-stabilized MTP (25 lM) for 30 min
GE. Similar results were obtained in three independent assays. A typical experiment
Tau bound to MTP (pellet)
Con. N-Hcy-tau
15 0 0.15 1.5 15
86.11 71.14 69.01 34.73 13.89
22.13 80.63 79.35 79.98 76.87
ed using 1-D Total Lab TL120 software (Nonlinear Dynamics Ltd., UK). The average
he bounded and unbounded for N-Hcy-tau species and assembled and unassembled
Fig. 2. MTP assembly assay in the presence or absence of unmodiﬁed tau or N-Hcy-tau species. MTP assembly, as determined by turbidimetry at 350 nm, was performed in
the absence or presence of unmodiﬁed or N-Hcy-tau species. Tubulin (25 lM) was incubated without or with unmodiﬁed tau or N-Hcy-tau species (10 lM) and polymerized
in assembly buffer to steady state at 37 C.
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correlated with the impact on nucleation and assembly dynamics.
To investigate this possible effect, we monitored the raise of tur-
bidity at 350 nm, as a probe of MTP polymerization behavior
in vitro, in the absence or presence of unmodiﬁed or N-Hcy-tau
species (Fig. 2). The lag phase, which is strongly related to nucle-
ation efﬁciency [29], was shortened in the presence of unmodiﬁed
and N-homocysteinylated (0.15 mM tHcy) tau (from 106 ± 3.04 to
49 ± 4.18 and 48 ± 2.27), indicating the promotion of MTP nucle-
ation. In contrast, N-Hcy-tau (1.5 and 15 mM tHcy) failed to en-
hance MTP nucleation, similar to the negative control (no tau).Fig. 3. Determination of the role of unmodiﬁed tau or N-Hcy-tau species in the critica
samples were pre-achieved to steady state at different total tubulin concentrations (Ct) a
Ct, giving an apparent Cc as the intercept and Fi as the slope. Each point is the average of
curve ﬁtting processing for each group.A short lag phase and steep rise in OD350, which is proportional
to the initial rate, are usually related to one another. The reason is
that, in principal, a short lag phase indicates efﬁcient nucleation.
This in turn, means a speciﬁc binding of tau to tubulin, and since
this is one of the main factors determining the assembly rate.
Unmodiﬁed and N-homocysteinylated (0.15 mM tHcy) tau en-
hanced the initial rates in a similar manner, whereas, these rates
in the presence of N-Hcy-tau (15 mM tHcy) and tubulin alone
(no tau) were signiﬁcantly low. Final plateau at steady state asso-
ciates with total polymer mass [29]. Obviously, there are signiﬁ-
cant differences in the population of MTP assembled in thel concentration (Cc) and unassembled fractions of tubulin (Fi). Preassembled MTP
nd separated from unassembled tubulin in the supernatant (Cs). Cs is plotted against
at least three independent measurements and the lines are the results after a linear
Fig. 4. Electron micrographs of unmodiﬁed and N-homocysteinylated tau-induced
MTP assembly. MTP polymerized in assembly conditions as described in Section 2
in the presence of (A), unmodiﬁed tau (B), N-Hcy-tau (15 mM tHcy) and negative
stained at steady state. The bar is corresponds to 50 nm.
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tion of modiﬁer, we observed a gradual decrease of the OD350. Ex-
tent of assembly decreased by 7% for N-Hcy-tau (0.15 mM tHcy),
12.5% for N-Hcy-tau (1.5 mM tHcy) and 28% for N-Hcy-tau
(15 mM tHcy), to compare with unmodiﬁed tau. In addition, for
N-Hcy-tau (15 mM tHcy), we observed a destabilizing effect on
the MTP lattice after reaching the steady state.
These in vitro ﬁndings show that N-homocysteinylation of tau
affects its functional activity, which is critical for binding and sta-
bilization of MTP. Our results conﬁrmed the importance effect of
lysine modiﬁcations in MTP assembly and dynamics [17]. It has
been reported that K280, which is located at MTBR (275VQI-
INKK281), is critical for binding to MTP [30]. Our unpublished mass
spectrometry data revealed that in the presence of molar excess of
tHcy (15 mM), K280 undergoes the modiﬁcation. Then, impaired
binding of tau to MTP, especially in the presence of N-Hcy-tau(15 mM tHcy), could be attributed to modiﬁcation of this lysine
group.
Tau increases the rate of MTP elongation by decreasing tubulin
dissociation during assembly. This lowers the critical concentra-
tion for elongation [31]. To learn how N-homocysteinylation of
tau affects MTP assembly, we determined the critical concentration
of tubulin. To achieve this, various concentrations of preassembled
tubulin (Ct) are plotted as a function of unassembled tubulin (Cs) in
the supernatant, in the presence or absence of unmodiﬁed or N-
homocysteinylated tau species (Fig. 3). We found that in the pres-
ence of N-Hcy-tau, critical concentration increased from
1.95 ± 0.18 lM (0.15 mM tHcy) to 2.42 ± 0.31 lM (15 mM tHcy),
suggesting a functional deﬁcit of tau caused by N-homocysteinyla-
tion. Also, according to earlier reports, the main effect of tau is to
stabilize MTP against disassembly and cooperation to involvement
of more tubulin into the MTP lattice [32]. Due to this fact, the frac-
tion of disassembled tubulin, in the presence of native tau, is less
than this fraction for tubulin alone. Our results show that this frac-
tion increases upon tau N-homocysteinylation and is dependent on
the state of tau modiﬁcation.
The change in absorbance at 350 nm is characteristic of the for-
mation of MTP polymers [33], but it is not clear what exact struc-
tures are being formed, particularly in the presence of high level
N-homocysteinylated tau (tHcy 15 mM). Then, we decided to
investigate the morphology of the structures formed in the reac-
tion mixtures. To this aim, we carried out the negative staining
electron microscopy at steady state of MTP assembly, in the pres-
ence of unmodiﬁed or N-homocysteinylated (tHcy 15 mM) tau. A
typical and normal MTP were seen in assembly promoted by
unmodiﬁed tau (Fig. 4A), but high level N-homocysteinylated tau
(tHcy 15 mM) disrupted MTP assembly after reaching steady state
(Fig. 4B), in consistence with time dependent decrease in absor-
bance after reaching this state (see Fig. 2). Disassembled and/or
unassembled MTP protoﬁlaments and ribbons, which are charac-
teristics of disrupted and unstable MTP, were observed in
Fig. 4B. Based on the MTP assembly results (Fig. 2), the initial
phases of assembly, for both tubulin alone and N-Hcy-tau
(15 mM tHcy), are similar. It seems that there isn’t any speciﬁc
interaction between N-Hcy-tau (15 mM tHcy) and tubulin in the
initial steps of assembly, but, in the case of absence of any inter-
action, the last phase and steady state of assembly should be the
same as tubulin alone. According to the destabilizing effect of
modiﬁed tau (Fig. 2) and perturbation of MTP (Fig. 4B), it could
be deduce that N-Hcy-tau (15 mM tHcy) interacts with MTP but
not in a speciﬁc manner. This un-speciﬁcity could be due to the
interaction of unmodiﬁed lysine groups (around 18) with tubulin
C-terminals in the lattice. Therefore, we can conclude that modiﬁ-
cation of tau with high level of tHcy interferes with the normal
activity of tau by abrogating the ability of this protein to stabilize
MTP, and N-homocysteinylation is sufﬁcient to induce this loss of
function.
Axonal transport mechanism, in central nervous system, relies
on MTP as routes and tracks that are stabilized by tau isoforms.
This implies that the ability of tau to maintain MTP tracks seems
to depend on the lack of pathogenic modiﬁcations at MTBRs. In this
context, we presented distinct differences in MTP assembly param-
eters in vitro, depending upon the N-homocysteinylation status of
human tau (4R/1N). Our in vitro results indeed, show that N-
homocysteinylation of tau at critical amino acids decreases the
binding ability of tau to MTP, leading to the instability of MTP
and impaired its ability to promote MTP assembly. To our knowl-
edge, these results are the ﬁrst to demonstrate the signiﬁcance of
this type of modiﬁcation on tau critical roles. While, as reported
here, the N-homocysteinylation state of tau had a signiﬁcant effect
on the binding and MTP assembly behaviors in vitro, the effect
in vivo has yet to be examined.
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